Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CellCarta acquires Biogazelle to strengthen its genomic capabilities and expand into digital PCR (dPCR) services 2021-12-14 20:25
Alterity Therapeutics Announces First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial 2021-12-14 20:25
CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd 2021-12-14 14:59
Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea 2021-12-14 13:34
Orelabrutinib Data Presented at the 63rd Annual Meeting of ASH 2021-12-14 12:50
Cargene Closes a US$19.2M Pre-A Round Led by BioTrack Capital 2021-12-14 09:00
Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy 2021-12-14 08:55
The New Era Biotechnology deepens cooperation between China and Belarus in the Great Stone China Belarus Industrial Park (CBIP) 2021-12-13 22:16
"Finally" User-friendly, Methylcellulose-free Solutions for Meat Substitutes using Citri-Fi® Citrus Fiber 2021-12-13 22:04
IASO Biotherapeutics and Innovent Biologics Announced Updated Clinical Data of BCMA CAR-T Therapy in Oral Presentation at 2021 ASH Annual Meeting 2021-12-13 12:14
Physicians At St. David's Medical Center Among First In Nation To Implant Neurostimulator Technology For Advanced Heart Failure 2021-12-13 10:08
Antengene Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate ATG-017 in Combination with Opdivo® (nivolumab) in Advanced Solid Tumors 2021-12-13 08:30
StemiRNA Therapeutics appoints Dr. Jack Hu as Chief Financial Officer 2021-12-13 07:00
Brii Bio Announces Amubarvimab/Romlusevimab Combination Retains Neutralizing Activity Against Omicron SARS-CoV-2 Variant 2021-12-12 18:50
Phase 3 Data Show That TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine Significantly Improves Event-Free Survival and Overall Survival in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia 2021-12-12 09:00
The New Era Biotechnology deepens cooperation between China and Belarus in the Great Stone China Belarus Industrial Park (CBIP) 2021-12-10 23:38
Qiming's Portfolio Company CANbridge Pharmaceuticals Lists on Main Board of HKEx 2021-12-10 15:15
Trajan to acquire LEAP PAL Parts 2021-12-09 21:00
The innovative software "CAAS vFFR" by Pie Medical Imaging for the non-invasive physiological assessment of intermediate coronary lesions is the subject of FAST III, a multicenter European clinical trial which will investigate the effectiveness of the vessel Fractional Flow Reserve (vFFR) guided revascularization as compared to conventional FFR guided revascularization 2021-12-09 21:00
Sciwind Biosciences Completes Enrollment in Phase 2 Clinical Trial of XW003 in Type 2 Diabetes Patients 2021-12-09 20:00
1 163 164 165 166 167 412